■ 证券代码：688135 证券简称：利扬芯片 公告编号：2025-051 证券代码：118048 转债简称：利扬转债 广东利扬芯片测试股份有限公司 关于续聘会计师事务所的公告 本公司董事会及全体董事保证公告内容不存在虚假记载、误导性陈述或者重大遗漏，并对其内容的真实 性、准确性和完整性承担个别及连带法律责任。 重要内容提示： ● 拟续聘的会计师事务所名称：立信会计师事务所（特殊普通合伙） 广东利扬芯片测试股份有限公司（以下简称"公司"）于2025年9月29日召开第四届董事会第十二次会 议、第四届监事会第十次会议，审议通过《关于续聘公司2025年度审计机构的议案》，同意公司续聘立 信会计师事务所（特殊普通合伙）（以下简称"立信"）为公司2025年度审计机构，该事项尚需提交股东 大会审议通过，现将相关事项公告如下： 一、拟聘会计师事务所的基本情况 2、投资者保护能力 截至2024年末，立信已提取职业风险基金1.71亿元，购买的职业保险累计赔偿限额为10.50亿元，相关职 业保险能够覆盖因审计失败导致的民事赔偿责任。 近三年在执业行为相关民事诉讼中承担民事责任的情况如下： （一）机构信息 1、基本信息 立信会计师 ...

每经头条（nbdtoutiao）——农夫大战怡宝，抢到更多蛋糕的却是宗馥莉！农夫绿瓶上市后，怡宝上 演"滑铁卢"：市占率大跌近5个百分点 2024年1至12月份，利扬芯片的营业收入构成为：测试收入占比92.26%，其他业务占比6.0%，晶圆磨切 服务占比1.74%。 截至发稿，利扬芯片市值为69亿元。 每经AI快讯，利扬芯片（SH 688135，收盘价：34.21元）9月29日晚间发布公告称，公司第四届第十二 次董事会会议于2025年9月29日在公司会议室以现场结合通讯方式召开。会议审议了《关于续聘公司 2025年度审计机构的议案》等文件。 （记者 王晓波） ...

利扬芯片上市募集资金总额为53,605.20万元；扣除发行费用(不含增值税)后，募集资金净额为47,094.26 万元。2020年11月5日披露的招股书显示，公司拟募集资金47,094.26万元，分别用于芯片测试产能建设 项目、研发中心建设项目、补充流动资金项目。 中国经济网北京9月21日讯利扬芯片(688135.SH)近期发布2025年半年度报告。2025年上半年，公司实现 营业收入2.84亿元，同比增长23.09%；归属于上市公司股东的净利润-706.11万元，去年同期为-844.42万 元；归属于上市公司股东的扣除非经常性损益的净利润-675.96万元，去年同期为-798.35万元；经营活 动产生的现金流量净额为1.01亿元。 | | | | 单位:元 币种:人民币 | | --- | --- | --- | --- | | 主要会计数据 | 本报告期 | 上年同期 | 本报告期比上 | | | (1-6月) | | 年同期增减(%) | | 营业收入 | 284, 036, 747, 38 | 230.754.593.03 | 23.09 | | 利润总额 | -8.946.556.63 | -16. ...

Summary of Key Points Core Viewpoint - The announcement details the shareholding structure and the results of the share reduction plans by key shareholders of Guangdong Liyang Chip Testing Co., Ltd, highlighting the completion of the planned share reductions and the current holdings of the shareholders [1][2][3][4]. Shareholding Structure - Key shareholder and core technical personnel Mr. Lu Xukun holds 272,073 shares, accounting for 0.1340% of the total share capital [1]. - Key shareholder and core technical personnel Mr. Zheng Chaosheng holds 120,698 shares, accounting for 0.0595% of the total share capital [1]. - Shareholder and director Mr. Qu Hao holds 7,181,680 shares, accounting for 3.5376% of the total share capital [1][3]. Share Reduction Plans - Mr. Lu Xukun planned to reduce his holdings by up to 250,000 shares (0.1231% of total shares) [1]. - Mr. Zheng Chaosheng planned to reduce his holdings by up to 58,000 shares (0.0286% of total shares) [1]. - Mr. Qu Hao planned to reduce his holdings by up to 1,600,000 shares (0.7881% of total shares) [1]. Implementation Results - Mr. Lu Xukun completed the reduction of 250,000 shares at a price range of 30.66 to 31.14 CNY per share, totaling approximately 7.72 million CNY [3][4]. - Mr. Zheng Chaosheng completed the reduction of 58,000 shares at a price range of 29.40 to 31.15 CNY per share, totaling approximately 1.73 million CNY [3][4]. - Mr. Qu Hao completed the reduction of 1,600,000 shares at a price range of 29.64 to 33.01 CNY per share, totaling approximately 48.77 million CNY [4].

Fundraising Overview - The company has been approved to issue convertible bonds totaling RMB 52 million, with a term of 6 years, and has successfully raised the full amount [2] - After deducting issuance costs of approximately RMB 7.11 million, the net amount raised is approximately RMB 51.29 million, which was fully received by July 8, 2024 [2] Fund Management - The company has established a fundraising management system in compliance with relevant regulations to protect the rights of small investors [3] - A tripartite supervision agreement has been signed with the project subsidiary and the sponsoring institution to ensure proper use of the raised funds [4][5] Special Account Management - The company has opened special accounts for the raised funds, with specific banks involved in the management of these accounts [6] - The company has decided to close the special accounts at two banks as the funds have been fully utilized, and the remaining interest will be transferred to the company's main account for working capital [8]

Core Viewpoint - Liyang Chip's 2025 semi-annual report indicates strong growth in integrated circuit testing revenue, driven by high demand and new customer product launches [1][2]. Group 1: Financial Performance - In the first half of 2025, Liyang Chip's revenue from integrated circuit testing reached 277 million yuan, a year-on-year increase of 21.85% [1]. - The second quarter saw record revenue of 150 million yuan, up 32.03% year-on-year, and a net profit of 523,400 yuan, reflecting a 105.96% increase [1]. - The company's profitability improved significantly in the second quarter after a challenging first quarter, with revenue increasing sequentially [1]. Group 2: Strategic Initiatives - The "One Body, Two Wings" strategy has begun to show results, focusing on integrated circuit testing while enhancing operational efficiency [2]. - The company has developed a comprehensive service chain covering wafer thinning, laser grooving, and stealth dicing, improving chip yield and reliability [2]. - The wafer thinning business achieved revenue of 6.75 million yuan in the first half of 2025, a substantial increase of 111.61% year-on-year [2]. Group 3: Collaborative Efforts - Liyang Chip has established an exclusive partnership with Azoteq to provide heterogeneous wafer stacking and testing services [3]. - The "TerraSight" project, developed in collaboration with Azoteq, successfully demonstrated its technology in July 2025, with plans for further testing in the second half of 2025 [3]. - The ongoing implementation of the "One Body, Two Wings" strategy positions Liyang Chip to maintain a leading edge in the integrated circuit testing sector, supporting the development of the domestic chip industry [3].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expectation of stock price appreciation exceeding 15% over the next six months [5]. Core Insights - The company achieved record-high revenue in Q2 2025, driven by strong downstream demand from the smart driving and AI sectors, alongside proactive capacity expansion [2][3]. - The significant increase in net profit growth (831.03% YoY) outpaced revenue growth (47.53% YoY), showcasing operational leverage [2]. - The gross margin improved to 34.50%, up 5.94 percentage points YoY, primarily due to enhanced capacity utilization, which currently stands at 90% [2]. - The company is strategically investing in advanced packaging and testing capabilities to meet the rising demand for chip testing, particularly in 2.5D/3D and Chiplet technologies [3]. Financial Summary - For H1 2025, the company reported revenue of 634 million yuan and a net profit of 101 million yuan, with Q2 revenue reaching 349 million yuan [1]. - The revenue breakdown for different business segments includes wafer testing (355 million yuan), chip product testing (254 million yuan), and other businesses (29 million yuan), with respective YoY growth rates of 49.32%, 71.57%, and -38.36% [2]. - The company forecasts net profits of 274 million yuan, 373 million yuan, and 506 million yuan for 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 44, 32, and 24 [3].

Core Viewpoint - The company has released its 2025 semi-annual report, detailing its operational results, financial status, and future development plans, emphasizing the importance of reviewing the full report for comprehensive understanding [1][10]. Group 1: Company Overview - The company is Guangdong Liyang Chip Testing Co., Ltd., with stock code 688135 and convertible bond code 118048 [6][19]. - The company held its 11th board meeting on August 25, 2025, with all directors present, ensuring compliance with relevant laws and regulations [7][8]. Group 2: Financial Data - The company raised a total of RMB 520 million through the issuance of convertible bonds, with a net amount of RMB 512.89 million after deducting issuance costs [20][21]. - The company has established a dedicated account for managing the raised funds, in compliance with regulatory requirements [22][23]. Group 3: Fund Management and Usage - The company has implemented a fund management system to ensure the efficient use of raised funds, including a tripartite supervision agreement with banks and the sponsor [22][23]. - As of June 30, 2025, the company has not used idle funds for temporary working capital or for repaying bank loans [27][29]. - The company has approved the use of up to RMB 20 million of idle funds for cash management, investing in low-risk financial products [28]. Group 4: Board and Supervisory Committee Resolutions - The board and supervisory committee have both approved the semi-annual report and the special report on the management and actual use of raised funds, confirming the accuracy and completeness of the information disclosed [36][38].

Group 1 - The supervisory board of Guangdong Liyang Chip Testing Co., Ltd. confirmed that the 2025 semi-annual report was prepared and reviewed in compliance with relevant laws, regulations, and internal management systems [1][2] - The content and format of the 2025 semi-annual report meet the requirements of the Shanghai Stock Exchange, accurately reflecting the company's disclosed information without any false records or misleading statements [1][2] - The supervisory board unanimously agreed that the management and actual use of the raised funds for the first half of 2025 complied with the relevant regulations and that the funds were stored and used specifically for their intended purpose [2]

Company Overview - Guangdong Liyang Chip Testing Co., Ltd. is listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board with the stock code 688135 [2] - The company reported total assets of approximately CNY 2.61 billion at the end of the reporting period, reflecting a 0.68% increase from the previous year [2] - The net assets attributable to shareholders increased by 1.82% to approximately CNY 1.13 billion [2] Financial Performance - The company's operating revenue for the reporting period was approximately CNY 284 million, representing a 23.09% increase compared to the same period last year [2] - The total profit for the period was a loss of approximately CNY 8.95 million, an improvement from a loss of CNY 16.37 million in the previous year [2] - The net profit attributable to shareholders was a loss of approximately CNY 7.06 million, compared to a loss of CNY 8.44 million in the same period last year [2] - The net cash flow from operating activities was approximately CNY 100.79 million, down 9.40% from the previous year [2] - The weighted average return on net assets improved to -0.64%, up from -0.76% [2] Shareholder Information - The total number of shareholders at the end of the reporting period was 15,099 [2] - The largest shareholder, Huang Jiang, holds 29.61% of the shares, amounting to approximately 59.95 million shares [5] - Other significant shareholders include Qu Hao with 3.55% and Zhang Liping with 3.07% [5]